MAPT and epilepsy: The findings from the present research suggest that the synergy of TDP‐43, tau and α‐synuclein may aggravate cell damage and tissue vulnerability and lead to an increased risk of developing seizure activity or epilepsy as the pathology progresses to more severe stages.